ResearcherPeking UniversityNo recent work listed

Wei Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7426-1874; OpenAlex author ID A5102709911. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/tcr.2020.02.78 ↗
Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. First author DOI 10.1007/s12032-014-0346-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei‐Min Tong · 1 shared paper, 2020 · strength 0.16
- Paper The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma. DOI 10.21037/tcr.2020.02.78 ↗
Wei Peng · 1 shared paper, 2014 · strength 0.07
- Paper Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. DOI 10.1007/s12032-014-0346-4 ↗
Jifeng Feng · 1 shared paper, 2014 · strength 0.07
- Paper Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. DOI 10.1007/s12032-014-0346-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.